Eventide Healthcare & Life Sciences Fund

U.S. News evaluated 33 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Eventide Funds funds

See full Health rankings

See more fund rankings

Performance

The fund has returned 40.24 percent over the past year.

Trailing Returns Updated 06.30.2014
Year to date 7.9%
1 Year 40.2%
3 Years (Annualized) N/A
5 Years (Annualized) N/A
10 Years (Annualized) N/A

See more ETNHX performance

Summary

The investment seeks to provide long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It is non-diversified.

Fees

Fees are Low compared to funds in the same category.
Eventide Healthcare & Life Sciences Fund has an expense ratio of 1.63 percent.

See more ETNHX fees

Risk

Risk is N/A compared to funds in the same category according to Morningstar.

See more ETNHX risk